Isotretinoin and iPledge: A view of results

Journal of the American Academy of Dermatology

Volumn 65, Issue 2, 2011, Pages 418-419

  Maloney, Mary E ^a   Stone, Stephen P ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ARTICLE; BIRTH CONTROL; DRUG EXPOSURE; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; PATIENT CARE; PATIENT SELECTION; PHARMACIST; PHYSICIAN; PREGNANCY; PREGNANCY TEST; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; TERATOGENICITY;

EID: 79960418301     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.04.006     Document Type: Editorial

References (5)

1. L. Abroms, E. Maibach, K. Lyon-Daniel, and S.R. Feldman What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med 3 2006 e483
2. US. Food and Drug Administration. iPLEDGE update. 2006. Available at: https://www.ipledgeprogram.com/default.aspx. Accessed December 2010.
3. Shin J, Cheetham TC, Wong L, Niu F, Kass E, Yoshinaga MA, et al. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol doi: 10.1016/j.jaad.2010.09.017. Published online May 12, 2011.
4. Huber MH. Review of data from SMART program. FDA Joint Dermatologic and Ophthalmic Drugs & Drug Safety and Risk Management Advisory Committee Meeting. 2004. February 26-27, 2004. Available at: http://www.fda.gov/ohrms/ dockets/ac/04/slides/4017s1.htm. Accessed December 2010.
5. US. Food and Drug Administration. 2007 Drug Safety and Risk Management Advisory Committee, Dermatologic and Ophthalmic Drugs Advisory Committee. Briefing Document. IPLEDGE year one Update. Available at: http://www.fda.gov/ ohrms/dockets/ac/07/briefing/2007-4311b1-02-ipledge.pdf. Accessed December 2010.